First-line Treatment with Long-acting Risperidone in Subjects with First-Episode Psychosis: Safety and Efficacy Results from a 6-month Interim Analysis.

Simple item page
dc.contributor.authorEmsley RA
dc.contributor.authorOosthuizen P
dc.contributor.authorKoen L
dc.contributor.authorNiehaus DJH
dc.contributor.authorMedori R
dc.date.accessioned2012-08-10T15:38:12Z
dc.date.available2012-08-10T15:38:12Z
dc.date.issued2006
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.descriptionGeneeskunde
dc.descriptionPsigiatrie
dc.identifier.urihttp://hdl.handle.net/10019.1/39304
dc.titleFirst-line Treatment with Long-acting Risperidone in Subjects with First-Episode Psychosis: Safety and Efficacy Results from a 6-month Interim Analysis.
dc.typeProceedings International
Files
Collections
2006 - Research Outputs